SanBio Co (TSE:4592) Long-Term Debt : 円397.00 Mil (As of Jan. 2024)

View and export this data going back to 2015. Start your Free Trial

What is SanBio Co Long-Term Debt?

SanBio Co's Long-Term Debt for the quarter that ended in Jan. 2024 was 円397.00 Mil.

SanBio Co's quarterly Long-Term Debt declined from Jul. 2023 (円531.00 Mil) to Oct. 2023 (円464.00 Mil) and declined from Oct. 2023 (円464.00 Mil) to Jan. 2024 (円397.00 Mil).

SanBio Co's annual Long-Term Debt declined from Jan. 2022 (円2,012.50 Mil) to Jan. 2023 (円665.00 Mil) and declined from Jan. 2023 (円665.00 Mil) to Jan. 2024 (円397.00 Mil).

SanBio Co Long-Term Debt Historical Data

The historical data trend for SanBio Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SanBio Co Long-Term Debt Chart

SanBio Co Annual Data

Trend

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

Long-Term Debt

Get a 7-Day Free Trial

3,500.00

2,525.00

2,012.50

665.00

397.00

SanBio Co Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Long-Term Debt	Get a 7-Day Free Trial															665.00	598.00	531.00	464.00	397.00

SanBio Co (TSE:4592) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

SanBio Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of SanBio Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

SanBio Co (TSE:4592) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SanBio Co Ltd (TSE:4592) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

SNBIF:USA

Address

8-1 Street Luke Tower 32nd Floor, Akashi-cho, Chuo-ku, Tokyo, JPN, 104-0044

Website

https://www.sanbio.com

SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.

SanBio Co (TSE:4592) Headlines

No Headlines